| C06807 |
Acetophenazine |
(P) unclassified |
| C07051 |
Indinavir |
(P) unclassified |
| C07055 |
Isopropamide |
(P) unclassified |
| C07506 |
Propantheline |
(P) unclassified |
| C07811 |
Hexocyclium |
(P) unclassified |
| C07814 |
Homatropine |
(P) unclassified |
| C07818 |
Mepenzolate |
(P) unclassified |
| C07849 |
Methantheline |
(P) unclassified |
| C07861 |
Tridihexethyl |
(P) unclassified |
| C12768 |
Timepidium bromide; Timepidium bromide anhydrous |
(P) unclassified |
| D00113 |
Atropine (USP); Atropen (TN) |
(P) unclassified |
| D00136 |
Haloperidol (JP19/USP/INN); Haldol (TN) |
(P) Enzyme: CYP3A4 / Target: DRD2 |
| D00138 |
Scopolamine (INN); Transderm scop (TN) |
(P) unclassified |
| D00140 |
Erythromycin (JP19/USP/INN); Akne-mycin (TN); Eryc (TN); Erygel (TN); Pce (TN); Staticin (TN); T-stat (TN) |
(P) unclassified |
| D00147 |
Hyoscyamine (USP) |
(P) unclassified |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP19); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00197 |
Reserpine (JP19/USP/INN); Apoplon (TN); Serpalan (TN) |
(P) unclassified |
| D00198 |
Rescinnamine (JAN/INN); Tsuruselpi S (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP19/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
| D00232 |
Anisotropine methylbromide (USAN); Octatropine methylbromide (INN); Methyloctatropine bromide (JAN); Valpin (TN); Valpin 50 (TN) |
(P) unclassified |
| D00270 |
Chlorpromazine (USP/INN); Thorazine (TN) |
(P) Target: DRD2 |
| D00276 |
Clarithromycin (JP19/USP/INN); Biaxin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00282 |
Clotrimazole (JP19/USP/INN); Lotrimin (TN); Mycelex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00292 |
Dexamethasone (JP19/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP19/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 |
| D00295 |
Cimetidine (JP19/USP/INN); Tagamet (TN) |
(P) CYP inhibition: CYP3A4 |
| D00297 |
Digitoxin (JAN/USP/INN); Crystodigin (TN) |
(P) unclassified |
| D00298 |
Digoxin (JP19/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00308 |
Droperidol (JP19/USP/INN); Droleptan (TN); Inapsine (TN) |
(P) Target: DRD2 |
| D00318 |
Famotidine (JP19/USP/INN); Fluxid (TN); Pepcid (TN) |
(P) unclassified |
| D00322 |
Fluconazole (JP19/USP/INN); Diflucan (TN) |
(P) CYP inhibition: CYP3A4 |
| D00350 |
Itraconazole (JP19/USP); Itrizole (TN); Sporanox (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00351 |
Ketoconazole (JP19/USP); Nizoral (TN); Xolegel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00355 |
Lansoprazole (JP19/USP/INN); Prevacid (TN) |
(P) Enzyme: CYP3A4 |
| D00373 |
Thioridazine (USP/INN); Mellaril-S (TN) |
(P) Target: DRD2 |
| D00390 |
Triflupromazine (USP/INN); Vesprin (TN) |
(P) Target: DRD2 |
| D00397 |
Tropicamide (JP19/USP/INN); Mydriacyl (TN) |
(P) unclassified |
| D00403 |
Methotrimeprazine (USP); Levomepromazine (USAN/INN); Levoprome (TN) |
(P) Target: DRD2 |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00422 |
Ranitidine (USAN/INN) |
(P) unclassified |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 |
| D00440 |
Nizatidine (JP19/USP/INN); Acinon (TN); Axid (TN) |
(P) unclassified |
| D00455 |
Omeprazole (JP19/USP/INN); Prilosec (TN) |
(P) unclassified |
| D00465 |
Oxybutynin (USAN/INN); Anturol (TN); Oxytrol (TN) |
(P) Enzyme: CYP3A4 |
| D00479 |
Prochlorperazine maleate (JP19/USP); Compazine (TN) |
(P) Target: DRD2 |
| D00481 |
Propantheline bromide (JP19/USP/INN); Pro-banthine (TN) |
(P) unclassified |
| D00493 |
Prochlorperazine (JAN/USP/INN); Compro (TN) |
(P) Target: DRD2 |
| D00502 |
Pergolide mesylate (USP); Pergolide mesilate (JAN); Permax (TN) |
(P) Target: DRD2 |
| D00503 |
Perphenazine (JP19/USP/INN); Trilafon (TN) |
(P) Target: DRD2 |
| D00506 |
Phenobarbital (JP19/USP/INN); Luminal (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP19/USP/INN); Dilantin (TN) |
(P) unclassified |
| D00540 |
Glycopyrrolate (USP); Glycopyrronium bromide (JAN/INN); Cuvposa (TN); Robinul (TN); Seebri breezhaler (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 |
| D00554 |
Ethinyl estradiol (USP); Ethinylestradiol (JP19/INN); Estinyl (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00559 |
Pramipexole dihydrochloride (USP); Pramipexole hydrochloride hydrate (JAN); Pramipexole dihydrochloride monohydrate; Mirapex (TN) |
(P) Target: DRD2 |
| D00619 |
Verapamil hydrochloride (JP19/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00636 |
Amiodarone hydrochloride (JP19/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 |
| D00646 |
Tolterodine (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D00673 |
Ranitidine hydrochloride (JP19/USP); Zantac (TN) |
(P) unclassified |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00707 |
Fomepizole (JAN/USAN/INN); Antizol (TN) |
(P) CYP inhibition: CYP3A4 |
| D00715 |
Methscopolamine bromide (USP); Hyoscine methobromide (INN); Pamine (TN) |
(P) unclassified |
| D00716 |
Clidinium bromide (USP/INN); Quarzan (TN) |
(P) unclassified |
| D00717 |
Dicyclomine hydrochloride (JAN/USP); Dicycloverine hydrochloride; Bentyl (TN); Urispas (TN) |
(P) unclassified |
| D00719 |
Hyoscyamine sulfate (USP); Hyoscyamine sulfate dihydrate; Egacene (TN) |
(P) unclassified |
| D00720 |
Mepenzolate bromide (JP19/INN); Cantil (TN) |
(P) unclassified |
| D00721 |
Methanthelinium bromide (INN); Methantheline bromide; Banthine (TN) |
(P) unclassified |
| D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP19); Ditropan (TN); Gelnique (TN) |
(P) Enzyme: CYP3A4 |
| D00723 |
Tridihexethyl chloride (BAN); Pathilon (TN) |
(P) unclassified |
| D00724 |
Rabeprazole sodium (JP19/USP); Aciphex (TN); Pariet (TN) |
(P) Enzyme: CYP3A4 |
| D00728 |
Bismuth subsalicylate (JAN/USP); Pepto-bismol (TN) |
(P) unclassified |
| D00731 |
Magnesium hydroxide (JAN/USP); Magnesia, (Milk of) (USP); Milmag (TN); Mint-o-mag (TN) |
(P) unclassified |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00774 |
Orphenadrine citrate (USP); Norflex (TN) |
(P) unclassified |
| D00778 |
Benztropine mesylate (USP); Benztropine mesilate (JAN); Cogentin (TN) |
(P) unclassified |
| D00779 |
Biperiden (JAN/USP/INN); Akineton (TN) |
(P) unclassified |
| D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP19); Parlodel (TN) |
(P) Enzyme: CYP3A4 / Target: DRD2 / CYP inhibition: CYP3A4 |
| D00782 |
Procyclidine hydrochloride (USP); Kemadrin (TN) |
(P) unclassified |
| D00784 |
Ropinirole hydrochloride (JAN/USP); Requip (TN) |
(P) Target: DRD2 |
| D00787 |
Trihexyphenidyl hydrochloride (JP19/USP); Artane (TN) |
(P) unclassified |
| D00788 |
Acetophenazine maleate (USAN); Tindal (TN) |
(P) Target: DRD2 |
| D00789 |
Chlorpromazine hydrochloride (JP19/USP); Sonazine (TN) |
(P) Target: DRD2 |
| D00791 |
Fluphenazine hydrochloride (JAN/USP); Prolixin (TN) |
(P) Target: DRD2 |
| D00792 |
Fluphenazine enanthate (JP19/USP); Prolixin enanthate (TN) |
(P) Target: DRD2 |
| D00793 |
Fluphenazine decanoate (JAN/USP); Prolixin decanoate (TN) |
(P) Target: DRD2 |
| D00795 |
Mesoridazine besylate (USP); Serentil (TN) |
(P) Target: DRD2 |
| D00797 |
Promazine hydrochloride (USP); Sparine (TN) |
(P) Target: DRD2 |
| D00798 |
Thioridazine hydrochloride (JP19/USP); Mellaril (TN) |
(P) Target: DRD2 |
| D00799 |
Trifluoperazine hydrochloride (JAN/USP); Stelazine (TN) |
(P) Target: DRD2 |
| D00800 |
Triflupromazine hydrochloride (JAN/USP); Vesprin (TN) |
(P) Target: DRD2 |
| D00824 |
Fluvoxamine maleate (JP19/USP); Luvox (TN) |
(P) CYP inhibition: CYP3A4 |
| D00831 |
Mefloquine hydrochloride (JP19/USP); Lariam (TN) |
(P) unclassified |
| D00851 |
Erythromycin estolate (USP); Erythromycin estorate (JAN); Ilosone (TN) |
(P) unclassified |
| D00854 |
Quinupristin and dalfopristin; Synercid (TN) |
(P) CYP inhibition: CYP3A4 |
| D00897 |
Indinavir sulfate (USP); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00932 |
Calcium carbonate (USP); Precipitated calcium carbonate (JP19); Cal-sup (TN) |
(P) unclassified |
| D00960 |
Anastrozole (JP19/USP/INN); Arimidex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00961 |
Bicalutamide (JP19/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00987 |
Cabergoline (JP19/USP/INN); Cabaser (TN); Dostinex (TN) |
(P) Enzyme: CYP3A4 / Target: DRD2 |
| D01002 |
Cyclopentolate hydrochloride (JP19/USP); Cyclogyl (TN) |
(P) unclassified |
| D01003 |
Hexocyclium metilsulfate (INN); Hexocyclium methyl sulfate; Tral (TN) |
(P) unclassified |
| D01004 |
Homatropine hydrobromide (JP19/USP); Isopto homatropine (TN) |
(P) unclassified |
| D01005 |
Isopropamide iodide (JAN/USP/INN); Darbid (TN) |
(P) unclassified |
| D01006 |
Oxyphencyclimine hydrochloride (JAN); Daricon (TN) |
(P) unclassified |
| D01007 |
Propiverine hydrochloride (JP19); Bup-4 (TN); Mictonorm (TN) |
(P) Enzyme: CYP3A4 |
| D01051 |
Spiperone (JAN/USAN); Spiropitan (TN) |
(P) Target: DRD2 |
| D01077 |
Methylatropine nitrate (USAN); Atropine methonitrate (JAN/INN); Ekomine (TN) |
(P) unclassified |
| D01101 |
Bromperidol (JAN/USAN/INN); Impromen (TN) |
(P) Enzyme: CYP3A4 / Target: DRD2 |
| D01103 |
Trospium chloride (JAN/USP/INN); Spasmex (TN); Spasmoplex (TN) |
(P) unclassified |
| D01105 |
Moperone hydrochloride (JAN); Luvatren (TN) |
(P) Target: DRD2 |
| D01118 |
Profenamine hydrochloride (JAN); Ethopropazine hydrochloride; Parkin (TN); Parsidol (TN) |
(P) unclassified |
| D01130 |
Thiethylperazine maleate (JAN/USP); Norzine (TN) |
(P) Target: DRD2 |
| D01131 |
Lafutidine (JP19/INN); Protecadin (TN) |
(P) Enzyme: CYP3A4 |
| D01148 |
Tolterodine tartrate (JAN/USP); Detrol (TN); Detrusitol (TN) |
(P) Enzyme: CYP3A4 |
| D01165 |
Piperidolate hydrochloride (JAN); Dactil (TN) |
(P) unclassified |
| D01167 |
Magnesium oxide (JP19/USP); Magmitt (TN) |
(P) unclassified |
| D01193 |
Osutidine (JAN/INN); T 593 |
(P) unclassified |
| D01201 |
Tiemonium iodide (JAN/INN); Visceralgine (TN) |
(P) unclassified |
| D01203 |
Sodium bicarbonate (JP19/USP); Meylon (TN); Neut (TN) |
(P) unclassified |
| D01207 |
Omeprazole sodium (USAN); Losec sodium (TN) |
(P) unclassified |
| D01231 |
Piroheptine hydrochloride (JAN); Trimol (TN) |
(P) unclassified |
| D01235 |
Josamycin (JP19/USAN/INN); Leucomycin A3; JM |
(P) CYP inhibition: CYP3A4 |
| D01240 |
Deslanoside (JP19/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 |
| D01269 |
Solifenacin succinate (JAN/USAN/INN); Vesicare (TN) |
(P) Enzyme: CYP3A4 |
| D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D01297 |
Pirenzepine hydrochloride (USAN) |
(P) unclassified |
| D01315 |
Methylbenactyzium bromide (JP19/INN) |
(P) unclassified |
| D01321 |
Zotepine (JAN/INN); Setous (TN) |
(P) Target: DRD2 |
| D01322 |
Troleandomycin (USAN/INN); Triacetyloleandomycin (JAN); TAO; Tao (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01339 |
Midecamycin (JP19/INN); Medemycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01359 |
Etomidoline (JAN/INN); Smedolin (TN) |
(P) unclassified |
| D01361 |
Erythromycin ethylsuccinate (JP19/USP); E.E.S. (TN); Eryped (TN); Erythrocin W (TN) |
(P) unclassified |
| D01377 |
Prifinium bromide (JAN/INN); Padrin (TN) |
(P) unclassified |
| D01412 |
Perazine maleate (JAN) |
(P) Target: DRD2 |
| D01429 |
Fosfluconazole (JAN/INN); Prodif (TN) |
(P) CYP inhibition: CYP3A4 |
| D01446 |
Magnesium carbonate (JP19/USP) |
(P) unclassified |
| D01447 |
Thioproperazine mesilate (JAN); Thioproperazine mesylate |
(P) Target: DRD2 |
| D01448 |
Trifluoperazine maleate (JAN) |
(P) Target: DRD2 |
| D01451 |
Scopolamine butylbromide (JP19); Butylscopolamine bromide; Buscopan (TN) |
(P) unclassified |
| D01463 |
Diponium bromide (JAN/INN); Dipenine bromide |
(P) unclassified |
| D01467 |
Roxatidine acetate hydrochloride (JP19/USAN); Altat (TN) |
(P) unclassified |
| D01482 |
Pipamperone hydrochloride (JAN) |
(P) Target: DRD2 |
| D01485 |
Propericiazine (JAN); Periciazine; Neuleptil (TN) |
(P) Target: DRD2 |
| D01491 |
Butropium bromide (JP19/INN); Coliopan (TN) |
(P) unclassified |
| D01520 |
Levomepromazine hydrochloride (JAN/USAN); Nozinan (TN) |
(P) Target: DRD2 |
| D01521 |
Pipethanate hydrochloride (JAN); Glymor (TN) |
(P) unclassified |
| D01538 |
Valethamate bromide (JAN); Shinmetane (TN) |
(P) unclassified |
| D01548 |
Mosapramine hydrochloride (JAN); Cremin (TN) |
(P) Target: DRD2 |
| D01600 |
Diphenylpiperidinomethyldioxolan iodide (JAN); Anacolin; Gastrophyllin-A (TN) |
(P) unclassified |
| D01636 |
Midecamycin acetate (JP19); Miocamycin; Miocamycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01648 |
Hyoscyamine methylbromide (JAN) |
(P) unclassified |
| D01659 |
Syrosingopine (JAN/INN); Siringina (TN) |
(P) unclassified |
| D01698 |
Dalcotidine (JAN/INN); KU 1257 |
(P) unclassified |
| D01699 |
Darifenacin hydrobromide (JAN/USAN); Enablex (TN) |
(P) Enzyme: CYP3A4 |
| D01815 |
Oxapium iodide (JP19/INN); Espalexan (TN) |
(P) unclassified |
| D01860 |
Perazine dimalonate (JAN) |
(P) Target: DRD2 |
| D01861 |
Pibutidine hydrochloride (JAN); IT 066 |
(P) unclassified |
| D01871 |
Methixene hydrochloride (USAN); Metixene hydrochloride (JAN); Methixene hydrochloride hydrete; Trest (TN) |
(P) unclassified |
| D01875 |
Tiquizium bromide (JAN/INN); Thiaton (TN) |
(P) unclassified |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) Enzyme: CYP3A4 / Target: DRD2 |
| D01920 |
Tenatoprazole (JAN/INN); TU 199 |
(P) unclassified |
| D01929 |
Tiotropium bromide hydrate (JAN); Tiotropium bromide monohydrate; Spiriva (TN) |
(P) unclassified |
| D01946 |
Oxitropium bromide (JAN/INN); Tersigan (TN) |
(P) unclassified |
| D01950 |
Dimethylaminoethyl reserpilinate dihydrochloride (JAN); Paratensiol |
(P) unclassified |
| D01972 |
Lanatoside C (JAN/INN); Digilanogen C (TN) |
(P) unclassified |
| D01976 |
N-Methylscopolamine methylsulfate (JAN); Daipin (TN) |
(P) unclassified |
| D01980 |
Luliconazole (JAN/USAN/INN); Lulicon (TN); Luzu (TN) |
(P) CYP inhibition: CYP3A4 |
| D01984 |
Esomeprazole magnesium (USP); Esomeprazole magnesium hydrate (JP19); Esomeprazole magnesium trihydrate; Nexium (TN) |
(P) unclassified |
| D02004 |
Apomorphine hydrochloride (USP); Apomorphine hydrochloride hydrate (JAN); Apokyn (TN); Ixense (TN); Uprima (TN) |
(P) Target: DRD2 |
| D02009 |
Erythromycin lactobionate (JP19/USP); Erythrocin (TN) |
(P) unclassified |
| D02012 |
Dihydroxyaluminum aminoacetate (JAN/USP); Alminium glycinate |
(P) unclassified |
| D02022 |
Prochlorperazine mesilate (JAN); Prochlorperazine dimethanesulfonate; Novamin (TN) |
(P) Target: DRD2 |
| D02035 |
Timiperone (JAN); Tolopelon (TN) |
(P) Target: DRD2 |
| D02037 |
Perphenazine maleate (JP19); PZC (TN) |
(P) Target: DRD2 |
| D02069 |
Atropine sulfate (JP19/USP); Ryjusea (TN) |
(P) unclassified |
| D02070 |
Homatropine methylbromide (USP); Equipin (TN) |
(P) unclassified |
| D02071 |
Scopolamine hydrobromide (USP); Scopolamine hydrobromide hydrate (JP19); Scopolamine hydrobromide trihydrate; Hysco (TN); Isopto hyoscine (TN) |
(P) unclassified |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP19); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
| D02106 |
Arsenic trioxide (JP19/USAN); Trisenox (TN) |
(P) unclassified |
| D02163 |
Fluphenazine maleate (JAN); Flumezin (TN) |
(P) Target: DRD2 |
| D02184 |
Erythromycin stearate (JP19/USP); Bristamycin (TN) |
(P) unclassified |
| D02212 |
Ipratropium bromide (USP); Ipratropium bromide hydrate (JP19); Atrovent (TN) |
(P) unclassified |
| D02246 |
Biperiden hydrochloride (JP19/USP); Tasmolin (TN) |
(P) unclassified |
| D02247 |
Biperiden lactate (JAN/USP); Tasmolin (TN) |
(P) unclassified |
| D02248 |
Levomepromazine maleate (JP19/USAN); Hirnamin (TN) |
(P) Target: DRD2 |
| D02354 |
Thiethylperazine (USAN/INN) |
(P) Target: DRD2 |
| D02356 |
Verapamil (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02371 |
Clocapramine hydrochloride hydrate (JP19); Clofekton (TN) |
(P) Target: DRD2 |
| D02372 |
Perospirone hydrochloride hydrate (JP19); Lullan (TN) |
(P) Target: DRD2 |
| D02416 |
Aluminum hydroxide (USP); Aluminum hydroxide, dried (USP); Dried aluminum hydroxide gel (JP19); ALterna GEL (TN); Dialume (TN) |
(P) unclassified |
| D02417 |
Flutropium bromide (JAN); Flutropium bromide monohydrate; Flubron (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02497 |
Fosamprenavir (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02523 |
Erythromycin acistrate (USAN); Erasis (TN) |
(P) unclassified |
| D02524 |
Erythromycin gluceptate (USP); Erythromycin glucoheptonate; Ilotycin gluceptate (TN) |
(P) unclassified |
| D02525 |
Erythromycin propionate (USAN) |
(P) unclassified |
| D02535 |
Timepidium bromide hydrate (JP19); Sesden (TN) |
(P) unclassified |
| D02555 |
Posaconazole (JAN/USAN/INN); Noxafil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02587 |
Metildigoxin (JP19); Lanirapid (TN) |
(P) unclassified |
| D02593 |
Pantoprazole sodium (USP); Pantoprazole sodium hydrate (JAN); Protonix (TN) |
(P) unclassified |
| D02599 |
Orphenadrine hydrochloride; Disipal (TN) |
(P) unclassified |
| D02604 |
Acepromazine maleate (USP) |
(P) Target: DRD2 |
| D02605 |
Methoxypromazine maleate |
(P) Target: DRD2 |
| D02607 |
Mepazine acetate |
(P) unclassified |
| D02608 |
Perazine fendizoate (JAN) |
(P) Target: DRD2 |
| D02609 |
Prochlorperazine edisylate (USP); Compazine syrup (TN) |
(P) Target: DRD2 |
| D02610 |
Thiethylperazine malate (JAN); Torecan (TN) |
(P) Target: DRD2 |
| D02620 |
Azaperone (USP/INN); Stresnil (TN) |
(P) unclassified |
| D02621 |
Fluanisone (INN) |
(P) unclassified |
| D02622 |
Pipamperone (USAN/INN); Floropipamide |
(P) Target: DRD2 |
| D02623 |
Moperone (INN) |
(P) Target: DRD2 |
| D02625 |
Trifluperidol (USAN/INN); Triperidol (TN) |
(P) Target: DRD2 |
| D02626 |
Bromperidol decanoate (USAN) |
(P) Enzyme: CYP3A4 / Target: DRD2 |
| D02627 |
Benperidol (USAN/INN); Anquil (TN) |
(P) Target: DRD2 |
| D02628 |
Milenperone (USAN/INN) |
(P) unclassified |
| D02642 |
Butaperazine (USAN) |
(P) unclassified |
| D02643 |
Butaperazine maleate (USAN) |
(P) unclassified |
| D02644 |
Carphenazine maleate (USAN); Proketazine (TN) |
(P) Target: DRD2 |
| D02651 |
Cloroperone hydrochloride (USAN) |
(P) unclassified |
| D02653 |
Cyclophenazine hydrochloride (USAN) |
(P) unclassified |
| D02668 |
Lenperone (USAN) |
(P) unclassified |
| D02671 |
Mesoridazine (USAN/INN); Lidanar (TN) |
(P) Target: DRD2 |
| D02679 |
Piperacetazine (USAN/INN); Quide (TN) |
(P) unclassified |
| D02680 |
Pipotiazine palmitate (USAN); Piportil depot (TN) |
(P) Target: DRD2 |
| D02686 |
Setoperone (USAN/INN) |
(P) unclassified |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
| D02732 |
Pranlukast hydrate (JP19); Onon (TN) |
(P) Enzyme: CYP3A4 |
| D02763 |
Actodigin (USAN/INN) |
(P) unclassified |
| D02807 |
Algeldrate (USAN/INN); Derma gran (TN) |
(P) unclassified |
| D02819 |
Almadrate sulfate (USAN) |
(P) unclassified |
| D02821 |
Almagate (USAN/INN); Almax (TN) |
(P) unclassified |
| D02844 |
Aluminum carbonate, basic (USAN); Basaljel (TN) |
(P) unclassified |
| D02861 |
Indinavir sulfate ethanolate (JAN); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02862 |
Aluminum phosphate (USP); Phosphaljel (TN) |
(P) unclassified |
| D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02876 |
Alvameline maleate (USAN) |
(P) unclassified |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03087 |
Benzetimide hydrochloride (USAN); Dioxatrine (TN) |
(P) unclassified |
| D03098 |
Berythromycin (USAN/INN); Erythromycin B |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03131 |
Bismuth, [milk of] (USP) |
(P) unclassified |
| D03165 |
Bromocriptine (USAN/INN) |
(P) Enzyme: CYP3A4 / Target: DRD2 / CYP inhibition: CYP3A4 |
| D03236 |
Synthetic aluminum silicate (JP19); Aluminum silicate, synthetic; Silicamin (TN) |
(P) unclassified |
| D03237 |
Natural aluminum silicate (JP19); Aluminum silicate, natural; Adsorbin (TN) |
(P) unclassified |
| D03238 |
Hydrotalcite (JAN/INN) |
(P) unclassified |
| D03264 |
Mazaticol hydrochloride hydrate (JAN); Mazaticol hydrochloride; Pentona (TN) |
(P) unclassified |
| D03271 |
Magnesium trisilicate (USP); Trimax (TN) |
(P) unclassified |
| D03274 |
Chlorpromazine hibenzate (JAN); Contomin (TN) |
(P) Target: DRD2 |
| D03276 |
Profenamine hibenzate (JAN); Parkin (TN) |
(P) unclassified |
| D03309 |
Calcium silicate (NF) |
(P) unclassified |
| D03503 |
Cimetidine hydrochloride (USP) |
(P) CYP inhibition: CYP3A4 |
| D03654 |
Darifenacin (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D03656 |
Darunavir (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 |
| D03666 |
Declenperone (USAN/INN) |
(P) unclassified |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
| D03711 |
Dexetimide (USAN/INN); (+)-Benzetimide |
(P) unclassified |
| D03814 |
Atropine methylbromide (JAN) |
(P) unclassified |
| D03819 |
Digitalis (USP); Digiglusin (TN) |
(P) unclassified |
| D03824 |
Dihexyverine hydrochloride (USAN) |
(P) unclassified |
| D03827 |
Dihydroxyaluminum sodium carbonate (USP); Rolaids (TN) |
(P) unclassified |
| D03833 |
Indinavir (USAN); Indinavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03835 |
Fosamprenavir calcium (USAN); Lexiva (TN); Telzir (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03837 |
Fosamprenavir sodium (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03889 |
Donetidine (USAN) |
(P) unclassified |
| D03921 |
Duoperone fumarate (USAN) |
(P) unclassified |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 |
| D04034 |
Chlorpromazine phenolphthalinate (JAN); Wintermin (TN) |
(P) Target: DRD2 |
| D04038 |
Perphenazine fendizoate (JAN); PZC (TN) |
(P) Target: DRD2 |
| D04054 |
Erythromycin salnacedin (USAN); Erythromycin salnacedin dihydrate |
(P) unclassified |
| D04056 |
Esomeprazole sodium (USAN); Nexium IV (TN) |
(P) unclassified |
| D04057 |
Esoxybutynin chloride (USAN) |
(P) unclassified |
| D04087 |
Ethybenztropine (USAN); Etybenzatropine (INN); Panolid (TN) |
(P) unclassified |
| D04098 |
Etintidine hydrochloride (USAN) |
(P) unclassified |
| D04116 |
Eucatropine hydrochloride (USP XXXII) |
(P) unclassified |
| D04393 |
Aluminum hydroxide and magnesium hydroxide; Aluminum hydroxide and magnesium hydroxide; Maalox (TN); Sakloft (TN) |
(P) unclassified |
| D04479 |
Hyoscyamine hydrobromide (USP) |
(P) unclassified |
| D04494 |
Icotidine (USAN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04680 |
Lavoltidine succinate (USAN) |
(P) unclassified |
| D04794 |
Lupitidine hydrochloride (USAN) |
(P) unclassified |
| D04832 |
Magaldrate (USP/INN); Riopan (TN) |
(P) unclassified |
| D04836 |
Magnesium phosphate (USP); Magnesium phosphate pentahydrate |
(P) unclassified |
| D04839 |
Magnesium silicate (JP19/NF); Florisil |
(P) unclassified |
| D04868 |
Mebeverine hydrochloride (USAN) |
(P) unclassified |
| D04965 |
Perphenazine hydrochloride; Perphenazine dihydrochloride; PZC (TN) |
(P) Target: DRD2 |
| D05004 |
Metiamide (USAN/INN) |
(P) unclassified |
| D05259 |
Omeprazole magnesium (USP); Prilosec OTC (TN) |
(P) unclassified |
| D05261 |
Omeprazole sodium injection (JAN); Omeprazole sodium hydrate; Omepral (TN) |
(P) unclassified |
| D05276 |
Pirenzepine hydrochloride hydrate (JP19); Gastrozepin (TN) |
(P) unclassified |
| D05306 |
Oxmetidine hydrochloride (USAN) |
(P) unclassified |
| D05307 |
Oxmetidine mesylate (USAN) |
(P) unclassified |
| D05351 |
Josamycin propionate (JP19); Josamy (TN) |
(P) CYP inhibition: CYP3A4 |
| D05353 |
Pantoprazole (USAN/INN) |
(P) unclassified |
| D05495 |
Pirenperone (USAN/INN) |
(P) unclassified |
| D05579 |
Potassium glucaldrate (USAN/INN); Aciquel (TN) |
(P) unclassified |
| D05699 |
Ranitidine bismuth citrate (USAN); Tritec (TN) |
(P) unclassified |
| D05705 |
Rauwolfia serpentina (USP); Rauwolfia extract; Himolfia (TN) |
(P) unclassified |
| D05722 |
Revaprazan hydrochloride (USAN) |
(P) unclassified |
| D05768 |
Rotigotine (JAN/USAN/INN); Neupro (TN) |
(P) Target: DRD2 |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05900 |
Timoprazole (INN) |
(P) unclassified |
| D05901 |
Picoprazole (INN) |
(P) unclassified |
| D05906 |
Leminoprazole (INN) |
(P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D05939 |
Sufotidine (USAN/INN) |
(P) unclassified |
| D06157 |
Tiotidine (USAN/INN) |
(P) unclassified |
| D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) Enzyme: CYP3A4 |
| D06355 |
Zaltidine hydrochloride (USAN) |
(P) unclassified |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 |
| D06436 |
Silodrate (USAN) |
(P) unclassified |
| D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06881 |
Acetyldigitoxin (INN); Acylanid (TN) |
(P) unclassified |
| D07065 |
Acepromazine (INN); Concentrat vo34 (TN) |
(P) Target: DRD2 |
| D07072 |
Niperotidine (INN) |
(P) unclassified |
| D07076 |
Camylofin (INN); Anafortan (TN) |
(P) unclassified |
| D07099 |
Cimetropium bromide (JAN/INN); Alginor (TN) |
(P) unclassified |
| D07147 |
Gitoformate (INN) |
(P) unclassified |
| D07166 |
Methoserpidine (INN) |
(P) unclassified |
| D07167 |
Bietaserpine (prop.INN) |
(P) unclassified |
| D07226 |
Fesoterodine (INN) |
(P) Enzyme: CYP3A4 |
| D07301 |
Phenglutarimide (INN) |
(P) unclassified |
| D07302 |
Bornaprine (INN) |
(P) unclassified |
| D07303 |
Tropatepine (INN) |
(P) unclassified |
| D07307 |
Cyamemazine (INN); Tercian (TN) |
(P) unclassified |
| D07308 |
Chlorproethazine (INN) |
(P) unclassified |
| D07309 |
Melperone (INN); Bunil (TN) |
(P) Target: DRD2 |
| D07406 |
Pimethixene (INN); Calmixene (TN) |
(P) unclassified |
| D07419 |
Almasilate (INN); Magnesium aluminosilicate (JP19/NF); Megalac (TN) |
(P) unclassified |
| D07471 |
Atazanavir (INN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D07511 |
Benzatropine (INN); Benztropine |
(P) unclassified |
| D07513 |
Benzetimide (INN); Spasmental [veterinary] (TN) |
(P) unclassified |
| D07555 |
Acetyldigoxin; Cedigossima (TN) |
(P) unclassified |
| D07556 |
beta-Acetyldigoxin; Acetyldigoxin beta isomer; Corotal (TN) |
(P) unclassified |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07584 |
Attapulgite (DCF); Donngel (TN) |
(P) unclassified |
| D07587 |
Bismuth subcitrate; Tripotassium dicitratobismuthate; De-Nol (TN) |
(P) unclassified |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP induction: CYP3A4 |
| D07610 |
Carbaldrate (INN); Basaljel (TN) |
(P) unclassified |
| D07685 |
Chlorproethazine hydrochloride; Neuriplege (TN) |
(P) unclassified |
| D07710 |
Clarithromycin lactobionate; Klacid (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07756 |
Cyamemazine tartrate; Tercian (TN) |
(P) unclassified |
| D07759 |
Cyclopentolate (INN); Bell Pentolate (TN) |
(P) unclassified |
| D07804 |
Dexetimide hydrochloride; Tremblex (TN) |
(P) unclassified |
| D07820 |
Dicycloverine (INN); Dicyclomine; Dicymine (TN) |
(P) unclassified |
| D07821 |
Dihexyverine (INN) |
(P) unclassified |
| D07865 |
Dixyrazine; Esucos (TN) |
(P) unclassified |
| D07909 |
Erythromycin thiocyanate; Erythrocin (TN) |
(P) unclassified |
| D07910 |
Erythromycin stinoprate (INN); Erysec (TN) |
(P) unclassified |
| D07917 |
Esomeprazole (INN); Inexium paranova (TN) |
(P) unclassified |
| D07928 |
Ethinylestradiol propanesulfonate; Turisteron (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07951 |
Fentonium bromide (INN); Ulcesium (TN) |
(P) unclassified |
| D07977 |
Fluphenazine (INN); Moditen (TN) |
(P) Target: DRD2 |
| D07984 |
Fluvoxamine (INN) |
(P) CYP inhibition: CYP3A4 |
| D08035 |
Haloperidol lactate; Haldol (TN) |
(P) Enzyme: CYP3A4 / Target: DRD2 |
| D08157 |
Mazaticol (INN) |
(P) unclassified |
| D08160 |
Mebeverine (INN); Arluy (TN) |
(P) unclassified |
| D08172 |
Melperone hydrochloride; Buronil (TN) |
(P) Target: DRD2 |
| D08194 |
Deserpidine (INN); Halmonyl (TN) |
(P) unclassified |
| D08209 |
Metixene (INN) |
(P) unclassified |
| D08259 |
Nelfinavir (INN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08305 |
Orphenadrine (INN); Mialgin (TN) |
(P) unclassified |
| D08325 |
Oxyphencyclimine (INN) |
(P) unclassified |
| D08341 |
Perphenazine decanoate; Trilafon dekanoat (TN) |
(P) Target: DRD2 |
| D08342 |
Perphenazine enantate; Perphenazine enanthate; Trilafon (TN) |
(P) Target: DRD2 |
| D08382 |
Piperidolate (INN) |
(P) unclassified |
| D08384 |
Pipethanate (INN); Piperilate |
(P) unclassified |
| D08385 |
Pipotiazine (INN); Piportil (TN) |
(P) Target: DRD2 |
| D08389 |
Pirenzepine (USAN/INN) |
(P) unclassified |
| D08395 |
Piroheptine (INN) |
(P) unclassified |
| D08425 |
Procyclidine (INN) |
(P) unclassified |
| D08426 |
Profenamine (INN) |
(P) unclassified |
| D08430 |
Promazine (INN); Combelen [veterinary] (TN) |
(P) Target: DRD2 |
| D08441 |
Propiverine (INN) |
(P) Enzyme: CYP3A4 |
| D08463 |
Rabeprazole (INN); Eraloc (TN) |
(P) Enzyme: CYP3A4 |
| D08494 |
Roxatidine (INN); Roxit (TN) |
(P) unclassified |
| D08495 |
Roxatidine acetate (BAN) |
(P) unclassified |
| D08522 |
Solifenacin (INN) |
(P) Enzyme: CYP3A4 |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) unclassified |
| D08585 |
Thioproperazine (INN) |
(P) Target: DRD2 |
| D08595 |
Tiemonium methylsulfate; Visceralgine (TN) |
(P) unclassified |
| D08616 |
Teneligliptin (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08636 |
Trifluoperazine (INN) |
(P) Target: DRD2 |
| D08637 |
Trifluperidol hydrochloride; Triperidol (TN) |
(P) Target: DRD2 |
| D08638 |
Trihexyphenidyl (INN); Apo-trihex (TN) |
(P) unclassified |
| D08653 |
Tropatepine hydrochloride; Lepticur (TN) |
(P) unclassified |
| D08774 |
Amoxicillin hydrate, clarithromycin and lansoprazole; Lansap (TN); Prevpac (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08837 |
Aclidinium bromide (JAN/USAN/INN); Tudorza (TN); Eklira (TN) |
(P) CYP inhibition: CYP3A4 |
| D08838 |
Acotiamide hydrochloride (USAN); Acotiamide hydrochloride hydrate (JAN) |
(P) unclassified |
| D08875 |
Bismuth citrate (USP) |
(P) unclassified |
| D08903 |
Dexlansoprazole (INN/USAN); Dexilant (TN) |
(P) Enzyme: CYP3A4 |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) Enzyme: CYP3A4 |
| D09012 |
Telaprevir (JAN/USAN/INN); Incivek (TN); Incivo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09216 |
Thiopropazate (INN) |
(P) unclassified |
| D09339 |
Esomeprazole potassium (USAN) |
(P) unclassified |
| D09394 |
Fidaxomicin (JAN/USAN); Dificid (TN); Dificlir (TN) |
(P) CYP inhibition: CYP3A4 |
| D09402 |
Darotropium bromide (USAN/INN) |
(P) unclassified |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 |
| D09756 |
Teneligliptin hydrobromide hydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09812 |
Bismuth magnesium aluminosilicate (JAN) |
(P) unclassified |
| D09819 |
Chlorpromazine tannate (JAN) |
(P) Target: DRD2 |
| D09837 |
Penaprazole sodium hydrate (JAN) |
(P) unclassified |
| D09847 |
Metildigoxin (INN); Medigoxin (BAN) |
(P) unclassified |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10120 |
Esomeprazole strontium (USAN); Esomeprazole strontium tetrahydrate |
(P) unclassified |
| D10127 |
Glycerol phenylbutyrate (JAN/USAN); Ravicti (TN) |
(P) unclassified |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10180 |
Umeclidinium (USAN) |
(P) unclassified |
| D10181 |
Umeclidinium bromide (JAN/USAN); Incruse ellipta (TN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10246 |
Omeprazole, clarithromycin and amoxicillin; Omeclamox-pak (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 |
| D10519 |
Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10582 |
Dasabuvir, ombitasvir, paritaprevir and ritonavir; Viekira pak (TN) |
(P) CYP inhibition: CYP3A4 |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) Enzyme: CYP3A4 |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10745 |
Ombitasvir, paritaprevir and ritonavir; Technivie (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) unclassified |
| D10895 |
Fosaprepitant (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 |
| D10938 |
Glycopyrronium (USAN) |
(P) unclassified |
| D10939 |
Glycopyrronium tosylate (USAN); Glycopyrronium tosilate hydrate (JAN); Glycopyrronium tosylate monohydrate; Qbrexza (TN); Rapifort (TN) |
(P) unclassified |
| D10989 |
Sofpironium bromide (JAN/USAN/INN); Ecclock (TN); Sofdra (TN) |
(P) Enzyme: CYP3A4 |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11114 |
Esomeprazole magnesium dihydrate |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) Enzyme: CYP3A4 |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) unclassified |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) Enzyme: CYP3A4 |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11557 |
Tecovirimat hydrate (JAN); Tecovirimat monohydrate; Tpoxx (TN); Tepoxx (TN) |
(P) unclassified |
| D11673 |
Berotralstat (USAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 |
| D11784 |
Vonoprazan (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) Enzyme: CYP3A4 |
| D11835 |
Vorasidenib citrate (USAN); Vorasidenib citric acid hydrate (JAN); Voranigo (TN) |
(P) unclassified |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(P) unclassified |
| D11968 |
Teneligliptin hydrobromide (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) Enzyme: CYP3A4 |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) Enzyme: CYP3A4 |
| D12246 |
Tegoprazan (INN) |
(P) unclassified |
| D12252 |
Iptacopan hydrochloride (USAN); Iptacopan hydrochloride hydrate (JAN); Iptacopan hydrochloride monohydrate; Fabhalta (TN) |
(P) CYP induction: CYP3A4 |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate; Tukysa (TN) |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) Enzyme: CYP3A4 |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12637 |
Darunavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12752 |
Darunavir propylene glycolate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12816 |
Dexlansoprazole sesquihydrate |
(P) Enzyme: CYP3A4 |
| D12837 |
Risovalisib mesilate hydrate (JAN); Risovalisib mesylate dihydrate; Haizexin (TN) |
(P) unclassified |
| D13012 |
Fexuprazan (INN); Abeprazan |
(P) unclassified |
| D13013 |
Ilaprazole (INN) |
(P) unclassified |
| D13197 |
Linaprazan glurate (USAN/INN) |
(P) unclassified |
| D13198 |
Linaprazan glurate hydrochloride (USAN) |
(P) unclassified |
| D13240 |
Zastaprazan (INN) |
(P) unclassified |
